IRIS
MACCARI, Rosanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.854
NA - Nord America 5.269
AS - Asia 2.678
SA - Sud America 898
AF - Africa 65
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.773
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.185
RU - Federazione Russa 2.967
SG - Singapore 1.151
CN - Cina 789
BR - Brasile 784
IE - Irlanda 760
SE - Svezia 687
UA - Ucraina 338
HK - Hong Kong 318
DE - Germania 310
IT - Italia 194
FI - Finlandia 149
GB - Regno Unito 138
FR - Francia 134
VN - Vietnam 105
IN - India 76
PL - Polonia 70
AR - Argentina 35
CA - Canada 35
BD - Bangladesh 34
MX - Messico 28
IQ - Iraq 27
AT - Austria 24
TR - Turchia 22
PK - Pakistan 21
MA - Marocco 19
UZ - Uzbekistan 19
EC - Ecuador 17
BE - Belgio 16
VE - Venezuela 16
NL - Olanda 15
JP - Giappone 13
KE - Kenya 12
ZA - Sudafrica 12
CL - Cile 10
CO - Colombia 10
ID - Indonesia 10
IR - Iran 10
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
ES - Italia 7
LT - Lituania 7
MY - Malesia 7
NP - Nepal 7
PE - Perù 7
PY - Paraguay 7
AU - Australia 6
BO - Bolivia 6
IL - Israele 6
JM - Giamaica 6
PH - Filippine 6
CR - Costa Rica 5
EG - Egitto 5
JO - Giordania 5
KR - Corea 5
OM - Oman 5
PT - Portogallo 5
RS - Serbia 5
TN - Tunisia 5
UY - Uruguay 5
AZ - Azerbaigian 4
LB - Libano 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
ET - Etiopia 3
GT - Guatemala 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LV - Lettonia 3
NO - Norvegia 3
RO - Romania 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BN - Brunei Darussalam 2
CG - Congo 2
CH - Svizzera 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
KW - Kuwait 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BT - Bhutan 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
MD - Moldavia 1
MM - Myanmar 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
SR - Suriname 1
Totale 14.768
Salva come PNG Salva come JPEG
Città #
Moscow 893
Dublin 760
Ashburn 652
Jacksonville 618
Singapore 606
Chandler 600
Dallas 522
Nyköping 437
Dearborn 390
Hong Kong 317
Beijing 303
San Jose 216
The Dalles 127
Princeton 120
Medford 116
Los Angeles 113
Cambridge 109
Lauterbourg 99
Ann Arbor 81
Boardman 79
Munich 79
Des Moines 72
Warsaw 67
Buffalo 62
New York 60
Messina 57
São Paulo 52
Ho Chi Minh City 48
Council Bluffs 45
Tianjin 39
San Mateo 34
Woodbridge 33
Guangzhou 31
Turku 31
Jinan 30
Wilmington 28
Lancaster 23
Orem 23
Belo Horizonte 22
Santa Clara 21
Vienna 21
Chennai 19
Denver 19
Rio de Janeiro 19
Seattle 19
Frankfurt am Main 18
Phoenix 18
Redondo Beach 17
Brussels 16
Haikou 15
Tashkent 15
Hanoi 14
Houston 14
Atlanta 13
Brasília 13
Nanjing 13
Stockholm 13
Curitiba 12
Salvador 12
Shanghai 12
Shenyang 12
Tokyo 12
Boston 11
Hefei 11
London 11
Montreal 11
Shenzhen 11
Taizhou 11
Baghdad 10
Chicago 10
Düsseldorf 10
Francofonte 10
Hebei 10
Johannesburg 10
Manchester 10
Mumbai 10
Taiyuan 10
Washington 10
Campinas 9
Milan 9
Nairobi 9
Pune 9
San Francisco 9
Sorocaba 9
Ardabil 8
Brooklyn 8
Fuzhou 8
Helsinki 8
Mexico City 8
Nanchang 8
Amsterdam 7
Changsha 7
Columbus 7
Contagem 7
Dhaka 7
Ankara 6
Auburn Hills 6
Charlotte 6
Fortaleza 6
Goiânia 6
Totale 8.684
Salva come PNG Salva come JPEG
Nome #
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 252
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 208
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 188
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 187
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 183
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 183
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 182
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 177
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 175
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 174
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 174
3-ARYL-5-ARYLIDENE-2-THIOXO-4-IMIDAZOLIDINONE DERIVATIVES AS NEW PTP1B ALLOSTERIC INHIBITORS 173
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 170
2,4-Thiazolidinediones as in vitro ALR2 inhibitors for the treatment of diabetic complications 169
Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor 168
2-(4-pyridyl)-Delta(2)-1,3,4-oxadiazolines from isonicotinoylhydrazones and diazomethane as potential antimycobacterial and anti-HIV agents .5. 166
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 165
Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures 164
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 163
(5-Arylidene-2,4-dioxothiazolidin-3-yl)acetic acids as aldose reductase inhibitors 163
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 162
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 160
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 159
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 158
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 158
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 157
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B 157
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 156
2,4-thiazolidinedione and 2-thioxo-4-thiazolidinone derivatives as aldose reductase inhibitors in the search for drugs to prevent long-term diabetes complications. 151
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 151
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 150
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 148
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 146
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 146
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 146
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatase inhibitors. 145
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 145
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 144
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. 143
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents 141
Sintesi di nuovi inibitori dell’aldoso reduttasi come agenti per il trattamento delle complicazioni diabetiche. 140
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 139
Design and synthesis of dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B 139
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 138
Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells 136
(5-Arylidene-2-thioxo-4-oxothiazolidin-3-yl)acetic acids endowed with chondroprotective and matrix metalloproteinase inhibitory activities 133
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 132
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 131
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions 131
Sintesi di 5-ariliden-2-fenilimino-4-tiazolidinoni attivi come inibitori di protein tirosina fosfatasi. 127
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 127
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 126
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 125
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 124
EVALUATION OF 4-THIAZOLIDINONE DERIVATIVES AS ALPHA-AMYLASE INHIBITORS 124
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 123
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 122
Sintesi e valutazione di derivati 2,4-tiazolidindionici non carbossilici come inibitori dell'aldoso reduttasi 121
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 121
Azione insulinomimetica di acidi [4-(5-ariliden-2-arilimino-4-ossotiazolidin-3-il)metil]benzoici attivi come inibitori delle fosfatasi PTP1B e LMW-PTP 121
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 118
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 117
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 117
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 117
Nuovi derivati 5-feniletossibenziliden-4-tiazolidinonici attivi come inibitori della protein tirosina fosfatasi 1B. 117
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 115
New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells 115
Progettazione e sintesi di 5-ariliden-4-tiazolidinoni e analoghi come inibitori di protein tirosina fosfatasi 114
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 113
Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targetsfor the Design of Novel Therapeutic Agents 112
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 109
Comparative activity of 5-arylidene-2-thioxo-4-thiazolidinone derivatives in chondrocytes and cartilage: MMP-3 inhibition and determination of GAGs release. 109
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 108
VALUTAZIONE DI COX-2 SELETTIVITÀ SU 3,3'-(1,2-ETANEDIIL)-BIS[2-(3,4-DIMETOSSIFENIL)-4-TIAZOLIDINONI] CHIRALI 106
HALOGENATED ISONIAZID DERIVATIVES AS POSSIBLE ANTIMYCOBACTERIAL AND ANTI-HIV AGENTS .3. 106
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 105
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 105
Valutazione dell'attività antidegenerativa di 2-tiosso-4-tiazolidinoni su colture di condrociti umani 105
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 105
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 104
Non-carboxylic acid 5-arylidene-2,4-thiazolidinedione derivatives as aldose reductase inhibitors 104
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 103
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 102
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 102
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 102
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 102
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 101
Halogenated isoniazid derivatives .6. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues 101
Protein-tyrosine phosphatase-1B mediates sleep fragmentation-induced insulin resistance and visceral adipose tissue inflammation in mice 101
HALOGENATED ISONIAZID DERIVATIVES .4. 1-METHYLIDENEAMINO-2- TRIFLUOROMETHYLAZIRIDINES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 100
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 99
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 98
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives 98
Tetraplex DNA specific ligand based on the fluorenone-carboxamide scaffold. 95
Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. 95
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 93
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell’aldoso reduttasi. 92
Sintesi, attività in vitro e SARs di 2,4-tiazolidindioni inibitori dell'aldoso reduttasi 91
Nuovi inibitori competitivi non fosforilati delle fosfotirosina protein fosfatasi. 90
Isonicotinoilidrazoni fluorurati: reattività ed attività antimicobatterica ed anti-HIV 89
Totale 13.362
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.883
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.883
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 0 0 0 0 0 0 39
2021/2022700 6 100 13 22 43 5 57 24 10 33 125 262
2022/20232.254 161 236 102 217 166 235 63 101 902 10 52 9
2023/2024395 32 78 49 35 46 80 6 20 0 13 2 34
2024/20252.140 21 21 41 135 82 38 57 445 578 128 188 406
2025/20266.715 304 501 483 477 513 1.542 820 841 785 243 127 79
Totale 14.858